Mutares Rights Issue Draws Strong Foreign Demand Ahead of Key Financial Reports

Mutares SE launches a EUR 24.50/share rights issue, aiming to raise up to EUR 105M. Funds will accelerate North American growth and address balance sheet covenants.

The rights issue for German investment firm Mutares SE & Co. KGaA is underway, with shareholder rights now trading on the Frankfurt Stock Exchange. The offering, priced at EUR 24.50 per share, allows holders of five existing shares to subscribe for one new share. The subscription period for retail investors runs until April 21, while the window to trade the rights themselves on the secondary market closes on April 16. Any unexercised rights will expire without compensation.

Institutional investor appetite provided a powerful prelude to the public offering. The private placement segment was nearly three times oversubscribed, attracting more than 30 long-term oriented investors. Over 60% of the orders originated from abroad, with particularly strong interest from the United States and United Kingdom. In this initial phase, 1,076,166 shares were placed, generating gross proceeds of EUR 26.4 million.

Should the full offering of up to 4.27 million new shares be placed, Mutares stands to raise gross proceeds of up to EUR 105 million. Management has earmarked approximately 80% of the funds to accelerate its North American expansion. The company, which already operates an office in Chicago, plans to establish a second US base. Its acquisition pipeline in the region targets companies with a combined revenue volume of roughly EUR 4.8 billion.

The capital increase also addresses a balance sheet concern. At the end of 2025, Mutares’s net debt-to-equity ratio breached an agreed covenant. The company has applied for a waiver until June 29, 2026, and presented a repayment plan. Starting in the second quarter, it intends to buy back at least EUR 25 million per quarter of its 2023/2027 bond, using the remaining 20% of the capital raise proceeds to strengthen its financial position.

Operational performance provides a solid foundation for this strategic move. Preliminary figures show group revenue rose to EUR 6.5 billion in 2025, with the holding company’s net income climbing to EUR 130.4 million. The firm’s acquisition engine remains active; after a first quarter featuring three new acquisitions and six signed exit transactions, Mutares plans three more signings and four closings in Q2. These include the already-signed sales of Conexus, Kalzip, inTime, and Relobus.

Looking ahead, Mutares forecasts 2026 revenue between EUR 7.9 billion and EUR 9.1 billion, with holding company profit projected in a range of EUR 165 million to EUR 200 million. The company targets a 25% annual growth rate for its holding net income through 2030.

A key date for shareholders is April 28. On that day, the new shares from the rights issue will be delivered, and the company will publish its full annual report for 2025. The stock currently trades at EUR 25.65, hovering just above its 52-week low. Investors will likely use the detailed annual report, followed by the Q1 2026 report on May 12, to assess the progress of Mutares’s ambitious growth strategy. The annual general meeting is scheduled for July 3.